Skip to main content
Addgene

pExodus CMV.Trex2
(Plasmid #40210)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 40210 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pUC
  • Backbone manufacturer
    In-house
  • Backbone size w/o insert (bp) 4389
  • Total vector size (bp) 5100
  • Modifications to backbone
    Multiple cloning site, CMV and T7 promoters
  • Vector type
    Mammalian Expression, Bacterial Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Three prime repair exonuclease 2
  • Alt name
    Trex2
  • Species
    M. musculus (mouse)
  • Insert Size (bp)
    711
  • Entrez Gene
    Trex2
  • Promoter CMV and T7

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site Nhe1 (not destroyed)
  • 3′ cloning site EcoR1 (not destroyed)
  • 5′ sequencing primer T7 FP
  • 3′ sequencing primer BGH RP
  • (Common Sequencing Primers)

Resource Information

  • Addgene Notes
  • A portion of this plasmid was derived from a plasmid made by
    We received the Trex2 ORF-containing construct from the laboratory of Daniel Stetson, University of Washington
  • Articles Citing this Plasmid

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pExodus CMV.Trex2 was a gift from Andrew Scharenberg (Addgene plasmid # 40210 ; http://n2t.net/addgene:40210 ; RRID:Addgene_40210)
  • For your References section:

    Coupling endonucleases with DNA end-processing enzymes to drive gene disruption. Certo MT, Gwiazda KS, Kuhar R, Sather B, Curinga G, Mandt T, Brault M, Lambert AR, Baxter SK, Jacoby K, Ryu BY, Kiem HP, Gouble A, Paques F, Rawlings DJ, Scharenberg AM. Nat Methods. 2012 Oct;9(10):973-5. doi: 10.1038/nmeth.2177. Epub 2012 Sep 2. 10.1038/nmeth.2177 PubMed 22941364